Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...

People who regularly engage in significant amounts of exercise, as endurance athletes do, may develop enlarged hearts. While ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment ...

Stress during the first years of life can have effects that last into adulthood. Less is known, however, about the possible ...

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System “Cardiac Dimensions is uniquely positioned to provide a safe ...

Because the human heart requires only a small amount of electrical stimulation, researchers were able to shrink their ...

Cardiac Dimensions secures $53M for heart device Federal Way rejects crisis center proposal Kirkland-based Cardiac Dimensions ...

Cardiac Dimensions ®, a leader in minimally invasive treatments for heart failure and functional mitral regurgitation (FMR), today announced the close of an oversubscribed $53 million Series E ...

March 20, 2025--(BUSINESS WIRE)--Cardiac Dimensions ®, a leader in minimally invasive treatments for heart failure and functional mitral regurgitation (FMR), today announced the close of an ...